Post Market Clinical Follow-Up Study of Excia T® Hip Prosthesis

August 10, 2023 updated by: Aesculap AG
Clinical and radiological 10 year results of Excia T® Hip Stem

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bad Rappenau, Germany, 74906
        • Vulpius Klinik
      • Stuttgart, Germany, 70176
        • Diakonie Klinikum Stuttgart

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

primary care clinic

Description

Inclusion Criteria:

  • Patient gave written informed consent
  • age ≥ 18 years

Exclusion Criteria:

  • pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Excia T®

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survival Rate of the Implant
Time Frame: 10 years
Kaplan-Meier Survival Rate up to 10 years
10 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hip disability and Osteoarthritis Outcome Score (HOOS)
Time Frame: preoperatively, intraoperatively + discharge, after 3 and 12 months 3, 5 and 10 years
Documentation of clinical outcome with HOOS Score
preoperatively, intraoperatively + discharge, after 3 and 12 months 3, 5 and 10 years
Change of functional outcome over follow-up period (Harris Hip Score (HHS))
Time Frame: at discharge, after 3 and 12 months 3, 5 and 10 years
The Harris Hip Score (HHS) is one of the most used scores in total hip arthroplasty, mainly combining range of motion questions with questions regarding daily life activities.
at discharge, after 3 and 12 months 3, 5 and 10 years
Pain Assessment
Time Frame: at 6 examinations during follow-up (discharge, after 3 and 12 months and 3, 5, and 10 years)
Pain will be measured with a Visual Analogue Scale (VAS), at rest and when walking on flat ground. The Visual Analog Scale (VAS) is a 10 cm line with anchor statements on the left (no pain) and on the right (extreme pain). The patients are asked to mark their current pain level on the line.
at 6 examinations during follow-up (discharge, after 3 and 12 months and 3, 5, and 10 years)
Shaftposition ap and lateral
Time Frame: 10 years
Radiological documentation of shaftposition in ap and lateral view discharge, after 3 and 12 months and 3, 5, and 10 years
10 years
Stress Shielding
Time Frame: 10 years
Radiological documentation of stress shielding after 3 and 12 months and 3, 5, and 10 years
10 years
Hypertrophies
Time Frame: 10 years
Radiological documentation of hypertrophies after 3 and 12 months and 3, 5, and 10 years
10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Peter Aldinger, Prof. Dr., Diakonie-Klinikum Stuttgart

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 3, 2014

Primary Completion (Actual)

October 6, 2015

Study Completion (Estimated)

July 1, 2025

Study Registration Dates

First Submitted

June 26, 2014

First Submitted That Met QC Criteria

July 10, 2014

First Posted (Estimated)

July 11, 2014

Study Record Updates

Last Update Posted (Actual)

August 14, 2023

Last Update Submitted That Met QC Criteria

August 10, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AAG-O-H-1401

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Arthritis

3
Subscribe